NextRNA Therapeutics

📍 Boston, United States🗓 Founded 2020👥 23 employees💰 Last funded Jan 2025
Biotechnology Research🌐 NextRNATx.com
Website LinkedIn
NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs (lncRNAs) with small molecules in oncology and neuroscience. Our proprietary computational engine, combined with deep lncRNA biology expertise and strong drug discovery capabilities, positions us well to unlock the therapeutic value of lncRNAs, a vast and promising target space. NextRNA has assembled an experienced team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in NextRNA Therapeutics?
NextRNA Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did NextRNA Therapeutics last raise funding?
The most recent investment in NextRNA Therapeutics recorded on gritt.io was in January 2025.
When was NextRNA Therapeutics founded?
NextRNA Therapeutics was founded in 2020.
What industry is NextRNA Therapeutics in?
NextRNA Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NextRNA Therapeutics based?
NextRNA Therapeutics is headquartered in Boston, United States.